12th Apr 2021 13:03
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | J.P. Morgan Securities LLC |
Company dealt in | AON plc |
Class of relevant security to which the dealings being disclosed relate (Note 2) | US$0.01 ordinary shares |
Date of dealing | 09 April 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Long | Short | |||||
Number | (%) | Number | (%) | |||
(1) Relevant securities | 6,306,077 2.79 | 2,034,749 0.90 | ||||
(2) Derivatives (other than options) | 1,764,165 0.78 | 37,772 0.02 | ||||
(3) Options and agreements to purchase/sell | 300,000 0.13 | |||||
Total | 8,070,242 3.57 | 2,372,521 1.05 | ||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale |
Number of relevant securities |
Price per unit (USD)
(Note 5) | |
Sale(Borrow Return)
Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases
Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales | 6,500
200 1,038 78 2,866 100 100 6 206 11 48 100 100 299 200 100 15 2 434 100 58 49 72 50 35 187 34 82 200 5 100 150 5 300 13 9 100 62 7 7 100 215 50 900 462 100 37 2 35 206 106 100 25 36
2 1,038 1,600 206 2 101 100 134 434 49 200 100 10 5 18 200 7 100 900 300 462 74 500 4 1 35 34 206 2 4 200 6 106 100 50 15 36 20 1 | N/A
236.3900 USD 236.9176 USD 236.9588 USD 237.0000 USD 237.1100 USD 237.1753 USD 237.1800 USD 237.1803 USD 237.2078 USD 237.2134 USD 237.2300 USD 237.2400 USD 237.2461 USD 237.2550 USD 237.2700 USD 237.2950 USD 237.3600 USD 237.3660 USD 237.4000 USD 237.4030 USD 237.4050 USD 237.4072 USD 237.4176 USD 237.4200 USD 237.4600 USD 237.4806 USD 237.4841 USD 237.4900 USD 237.5000 USD 237.5061 USD 237.5100 USD 237.5160 USD 237.5200 USD 237.5605 USD 237.5608 USD 237.6100 USD 237.6580 USD 237.7400 USD 237.7429 USD 237.7500 USD 237.7688 USD 237.7792 USD 237.7964 USD 237.8094 USD 237.8200 USD 237.8232 USD 237.8273 USD 237.9187 USD 237.9794 USD 238.0312 USD 238.1000 USD 238.3393 USD 238.3749 USD
234.8900 USD 236.9176 USD 237.0000 USD 237.1803 USD 237.1900 USD 237.2400 USD 237.2700 USD 237.2854 USD 237.3660 USD 237.4050 USD 237.4600 USD 237.4900 USD 237.5000 USD 237.5160 USD 237.5608 USD 237.6100 USD 237.7429 USD 237.7500 USD 237.7964 USD 237.8000 USD 237.8094 USD 237.8232 USD 237.8260 USD 237.8273 USD 237.8449 USD 237.9187 USD 237.9209 USD 237.9794 USD 238.0000 USD 238.0100 USD 238.0200 USD 238.0287 USD 238.0312 USD 238.0313 USD 238.3393 USD 238.3600 USD 238.3749 USD 238.3840 USD 238.4163 USD | |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (USD) (Note 5) |
Equity Swap | Decrease Long
Increase Long
Increase Short
| 434
5 900
360 678 7 | 237.3660 USD
237.5160 USD 237.7964 USD
236.7625 USD 237.0000 USD 237.7429 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price (USD) | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) Yes
Date of disclosure | 12 April 2021 |
Contact name | Alwyn Basch |
Telephone number | 0207 742 7407 |
If a connected EFM, name of offeree/offeror with which connected | N/A |
If a connected EFM, state nature of connection (Note 10) | N/A |
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name, e.g. call option | Written, or purchased | Number of relevant securities to which the option or derivative relates | Exercise price (Note 2) | Type, e.g. American, European etc. | Expiry date |
Call Option Call Option Call Option Call Option | Written Written Written Written | 46,200 71,700 77,400 104,700 | 270.00 270.00 270.00 270.00 | American American American American | 17/12/2021 17/12/2021 17/12/2021 17/12/2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
Related Shares:
Aon Cl A Ord